Language:

You are now leaving the Lundbeck Canada website

Links to sites outside of Lundbeck Canada are provided as resources to visitors and may not reflect Canada regulation or prescribing information. Lundbeck Canada accepts no responsibility for the content of linked sites.

Click here to proceed

Cancel

Ruled, but not ruined, by migraine

Audrey Craven knows the isolation migraine can cause. When her migraines were at their worst, Audrey Craven vowed to use her experience to help others navigate their migraine journey and feel less alone.

Read Story

This is Lundbeck

We are one of the only biopharmaceutical companies in the world focusing exclusively on brain diseases, and we’re set apart by our specialization. 

About Us

With more than 70 years of neuroscience expertise, Lundbeck has developed and commercialized some of the world's most widely prescribed therapies for brain diseases.

Our Science

LATEST NEWS

See All News

Come join us in making a difference to patients worldwide.

Job Opportunities

Through our sustainability strategy, we mitigate business risks, reduce negative impacts, and address societal challenges where possible.

Sustainability

A better life for people with brain diseases

At Lundbeck, we see patients as people and are committed to support the person behind the disease. 

Patients

Partnering

The complexity of brain diseases requires a concerted effort. We are committed to develop new and better treatment options from innovations born in house or externally.

Read More
Carlos Santillana Castillos living with Migraine

So Perfect, So Vulnerable

Read more
See all stories

Lundbeck at a glance

100

countries where our products are sold

5,500

employees supporting our purpose

1915

year Lundbeck was founded